Proteostasis Therapeutics Reports Second Quarter 2019 Financial Results and Provides Corporate Update
PROTEOSTASIS THERAPEUTICS (PTI)
Last proteostasis therapeutics earnings: 3/10 04:36 pm
Check Earnings Report
US:NYSE Investor Relations:
ir.proteostasis.com/investor-overview
Company Research
Source: PR Newswire
BOSTON, Aug. 7, 2019 /PRNewswire/ -- Proteostasis Therapeutics, Inc. (NASDAQ: PTI), a clinical stage biopharmaceutical company dedicated to the discovery and development of groundbreaking therapies to treat cystic fibrosis (CF) and other diseases caused by dysfunctional protein processing, today announced financial results for the second quarter ended June 30, 2019 and provided a corporate update. "PTI continues to advance the clinical development of our proprietary combination cystic fibrosis transmembrane conductance regulator (CFTR) modulators. We recently initiated dosing in the 28-day global Phase 2 study of our doublet (PTI-808 and PTI-801) and triplet (PTI-808, PTI-801 and PTI-428) combinations in F508del homozygous and heterozygous CF subjects and we remain on track to report top line results from this study in the first quarter of 2020. The CF community continues to seek alternatives to today's standard of care CFTR modulator therapy, validating PTI's mission to provide addi
Show less
Read more
Impact Snapshot
Event Time:
PTI
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PTI alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PTI alerts
High impacting PROTEOSTASIS THERAPEUTICS news events
Weekly update
A roundup of the hottest topics